• Profile
Close

Retroperitoneal lymph node dissection for testicular seminomas: Population-based practice and survival outcomes

World Journal of Urology Oct 17, 2017

Patel HD, et al. - This study expounded the current utilization of retroperitoneal lymph node dissection (RPLND) for testicular seminomas by stage and the implications for survival. The yielded data illustrated stability in the utilization of RPLND in the post-chemotherapy setting, over a 25-year period. Patients undergoing RPLND were at a greater risk. Nonetheless, stage-by-stage survival outcomes appeared comparable to men not undergoing RPLND. Upcoming trials implementing RPLND as the first-line modality for testicular seminoma or isolated retroperitoneal relapse would assist in an improved quantification of the relative recurrence and survival.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay